Immunotherapy Before Liver Cancer Surgery Can Kill Tumor, and Likely Residual Cancer Cells

Please share...Share on Google+Tweet about this on TwitterShare on StumbleUponShare on Facebook

Immunotherapy given before surgery caused liver cancer tumors to die off in one-third of the patients enrolled in a first-of-its-kind clinical trial, Mount Sinai researchers reported in The Lancet Gastroenterology & Hepatology in January.
Newswise: Latest News